MYC and ovarian carcinoma: Ovarian cancer cell lines treated with antisense phosphonothioate oligodeoxynucleotides targeting c-myc and c-erbb2 via cationic liposome reduced target gene expression and cell growth by 61.9 ± 9.3% and 64.5 ± 11.2%, respectively (p < 0.01) [56].